Discover 1,943 paid clinical trials in Fort Worth, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Fort Worth offers a range of medical research opportunities, focusing on conditions such as cancer, cardiovascular disease, PTSD, and COVID-19. Healthy volunteers looking for paid opportunities, as well as those with specific health concerns, can participate in studies at the city’s leading healthcare facilities, gaining access to new and innovative treatments while contributing to advancements in medical research.
Filter
2
Filter results
Results: 1,943
Study of STP938 (Dencatistat) in Advanced Solid Tumours
for
Solid Tumor
Location: Dallas TX, San Antonio TX, St. Petersburg FL
Sponsor: Step Pharma, SAS
Sex: All
Age: 18+
Code: NCT06297525
Phase 1, Recruiting
Asciminib Roll-over Study
for
Chronic Myelogenous Leukemia,
Location: Dallas TX, Houston TX, St Louis MO, Cincinnati OH,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 7 - 70+
Code: NCT04877522
Phase 4, Recruiting
Effectiveness and Safety of INGN 201 in Combination With Chemotherapy Versus Chemotherapy Alone
for
Carcinoma, Squamous Cell
Location: Dallas TX, Houston TX, Little Rock AR, Aurora CO,
Sponsor: Introgen Therapeutics
Sex: All
Age: 18+
Code: NCT00041626
Phase 3, Recruiting
Tailored Exercise Training Study Among Adults With HFpEF
for
HFpEF - Heart Failure With Preserved Ejection Fraction,
Location: Dallas TX
Sponsor: University of Texas Southwestern Medical Center
Sex: All
Age: 18+
Code: NCT07223242
Phase 2, Phase 3, Recruiting
BP1001-A in Patients With Advanced or Recurrent Solid Tumors
Location: Dallas TX, Houston TX, Detroit MI, Silver Spring MD
Sponsor: Bio-Path Holdings, Inc.
Sex: All
Age: 18+
Code: NCT04196257
Phase 1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
SW-682 in Advanced Solid Tumors
for
Advanced Solid Tumor, Mesothelioma, Malignant
Location: Dallas TX, Houston TX, Scottsdale AZ, Cleveland OH,
Sponsor: SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany
Sex: All
Age: 18+
Code: NCT06251310
Phase 1, Recruiting
First in Human Study of UCT-03-008 in Participants With Advanced Solid Tumors
for
Advanced Solid Tumor
Location: Dallas TX, Los Angeles CA
Sponsor: 1200 Pharma, LLC
Sex: All
Age: 18+
Code: NCT05103046
Phase 1, Recruiting
JAB-2485 Activity in Adult Patients With Advanced Solid Tumors
for
Solid Tumors, ER+ Breast Cancer,
Location: Dallas TX, St Louis MO, Salt Lake City UT, Detroit MI
Sponsor: Jacobio Pharmaceuticals Co., Ltd.
Sex: All
Age: 18+
Code: NCT05490472
Phase 1, Phase 2, Recruiting
CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis
for
Transthyretin Amyloid Cardiomyopathy (ATTR CM)
Location: Dallas TX, Plano TX, Austin TX, Houston TX,
Sponsor: Novo Nordisk A/S
Sex: All
Age: 18+
Code: NCT07207811
Phase 3, Recruiting
The Feasibility of Cream for Treatment of Neonatal Hypoglycemia
for
Neonatal Hypoglycemia
Location: McKinney TX
Sponsor: Baylor Research Institute
Sex: All
Age: 0
Code: NCT07217483
Recruiting
The Safety and Pharmacokinetics Preliminary Efficacy of IMP7068 in Patients With Advanced Solid Tumors
for
Advanced Solid Tumors
Location: Dallas TX, San Antonio TX, Fairway KS, Louisville KY,
Sponsor: Impact Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT04768868
Phase 1, Recruiting
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
for
Chronic Obstructive Pulmonary Disease
Location: DeSoto TX, Carrollton TX, Dallas TX, Allen TX,
Sponsor: Sanofi
Sex: All
Age: 40 - 70+
Code: NCT07190209
Phase 3, Recruiting
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype